Muller and Phipps (India) Ltd: Intrinsic Value & Share Price Analysis

Last Updated: January 2, 2026, 1:57 pm

All Competitor Stocks of Muller and Phipps (India) Ltd

Last Updated: December 23, 2025, 10:14 am

Below is a detailed analysis of the quarterly data for Muller and Phipps (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 1.82 Cr.. The value appears strong and on an upward trend. It has increased from 0.92 Cr. (Jun 2025) to 1.82 Cr., marking an increase of 0.90 Cr..
• For Expenses, as of Sep 2025, the value is 1.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.27 Cr. (Jun 2025) to 1.89 Cr., marking an increase of 0.62 Cr..
• For Operating Profit, as of Sep 2025, the value is -0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.35 Cr. (Jun 2025) to -0.07 Cr., marking an increase of 0.28 Cr..
• For OPM %, as of Sep 2025, the value is -3.85%. The value appears strong and on an upward trend. It has increased from -38.04% (Jun 2025) to -3.85%, marking an increase of 34.19%.
• For Other Income, as of Sep 2025, the value is 0.06 Cr.. The value appears to be declining and may need further review. It has decreased from 1.07 Cr. (Jun 2025) to 0.06 Cr., marking a decrease of 1.01 Cr..
• For Interest, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.02 Cr..
• For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
• For Profit before tax, as of Sep 2025, the value is -0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.70 Cr. (Jun 2025) to -0.03 Cr., marking a decrease of 0.73 Cr..
• For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
• For Net Profit, as of Sep 2025, the value is -0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.70 Cr. (Jun 2025) to -0.03 Cr., marking a decrease of 0.73 Cr..
• For EPS in Rs, as of Sep 2025, the value is -0.48. The value appears to be declining and may need further review. It has decreased from 11.20 (Jun 2025) to -0.48, marking a decrease of 11.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 3:30 am

Last Updated: September 5, 2025, 3:46 pm

Last Updated: December 4, 2025, 3:06 am

Below is a detailed analysis of the balance sheet data for Muller and Phipps (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 0.63 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.63 Cr..
• For Reserves, as of Sep 2025, the value is -2.06 Cr.. The value appears to be improving (becoming less negative). It has improved from -2.70 Cr. (Mar 2025) to -2.06 Cr., marking an improvement of 0.64 Cr..
• For Borrowings, as of Sep 2025, the value is 0.89 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 0.82 Cr. (Mar 2025) to 0.89 Cr., marking an increase of 0.07 Cr..
• For Other Liabilities, as of Sep 2025, the value is 6.84 Cr.. The value appears to be improving (decreasing). It has decreased from 6.97 Cr. (Mar 2025) to 6.84 Cr., marking a decrease of 0.13 Cr..
• For Total Liabilities, as of Sep 2025, the value is 6.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.72 Cr. (Mar 2025) to 6.30 Cr., marking an increase of 0.58 Cr..
• For Fixed Assets, as of Sep 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 6.24 Cr.. The value appears strong and on an upward trend. It has increased from 5.66 Cr. (Mar 2025) to 6.24 Cr., marking an increase of 0.58 Cr..
• For Total Assets, as of Sep 2025, the value is 6.30 Cr.. The value appears strong and on an upward trend. It has increased from 5.72 Cr. (Mar 2025) to 6.30 Cr., marking an increase of 0.58 Cr..

However, the Borrowings (0.89 Cr.) are higher than the Reserves (-2.06 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Muller and Phipps (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -12.11. This value is below the healthy minimum of 5. It has decreased from 11.65 (Mar 24) to -12.11, marking a decrease of 23.76.
• For Diluted EPS (Rs.), as of Mar 25, the value is -12.11. This value is below the healthy minimum of 5. It has decreased from 11.65 (Mar 24) to -12.11, marking a decrease of 23.76.
• For Cash EPS (Rs.), as of Mar 25, the value is -11.99. This value is below the healthy minimum of 3. It has decreased from 11.73 (Mar 24) to -11.99, marking a decrease of 23.72.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -33.24. It has decreased from -20.78 (Mar 24) to -33.24, marking a decrease of 12.46.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -33.24. It has decreased from -20.78 (Mar 24) to -33.24, marking a decrease of 12.46.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 94.66. It has increased from 66.25 (Mar 24) to 94.66, marking an increase of 28.41.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -11.03. This value is below the healthy minimum of 2. It has decreased from 6.36 (Mar 24) to -11.03, marking a decrease of 17.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is -11.15. This value is below the healthy minimum of 0. It has decreased from 6.28 (Mar 24) to -11.15, marking a decrease of 17.43.
• For PBT / Share (Rs.), as of Mar 25, the value is -12.11. This value is below the healthy minimum of 0. It has decreased from 11.65 (Mar 24) to -12.11, marking a decrease of 23.76.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -12.11. This value is below the healthy minimum of 2. It has decreased from 11.65 (Mar 24) to -12.11, marking a decrease of 23.76.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.11. This value is below the healthy minimum of 2. It has decreased from 11.65 (Mar 24) to -12.11, marking a decrease of 23.76.
• For PBDIT Margin (%), as of Mar 25, the value is -11.65. This value is below the healthy minimum of 10. It has decreased from 9.60 (Mar 24) to -11.65, marking a decrease of 21.25.
• For PBIT Margin (%), as of Mar 25, the value is -11.78. This value is below the healthy minimum of 10. It has decreased from 9.47 (Mar 24) to -11.78, marking a decrease of 21.25.
• For PBT Margin (%), as of Mar 25, the value is -12.79. This value is below the healthy minimum of 10. It has decreased from 17.58 (Mar 24) to -12.79, marking a decrease of 30.37.
• For Net Profit Margin (%), as of Mar 25, the value is -12.79. This value is below the healthy minimum of 5. It has decreased from 17.58 (Mar 24) to -12.79, marking a decrease of 30.37.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -12.79. This value is below the healthy minimum of 8. It has decreased from 17.58 (Mar 24) to -12.79, marking a decrease of 30.37.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -56.06 (Mar 24) to 0.00, marking an increase of 56.06.
• For Return on Capital Employeed (%), as of Mar 25, the value is -36.72. This value is below the healthy minimum of 10. It has decreased from 15.30 (Mar 24) to -36.72, marking a decrease of 52.02.
• For Return On Assets (%), as of Mar 25, the value is -13.22. This value is below the healthy minimum of 5. It has decreased from 13.83 (Mar 24) to -13.22, marking a decrease of 27.05.
• For Long Term Debt / Equity (X), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 0.2. It has increased from -0.59 (Mar 24) to -0.39, marking an increase of 0.20.
• For Total Debt / Equity (X), as of Mar 25, the value is -0.39. This value is within the healthy range. It has increased from -0.59 (Mar 24) to -0.39, marking an increase of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.08. It has increased from 0.82 (Mar 24) to 1.08, marking an increase of 0.26.
• For Current Ratio (X), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 1.5. It has decreased from 0.59 (Mar 24) to 0.54, marking a decrease of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.53 (Mar 24) to 0.51, marking a decrease of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 45.74. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 45.74, marking an increase of 45.74.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -11.55. This value is below the healthy minimum of 3. It has decreased from 6.18 (Mar 24) to -11.55, marking a decrease of 17.73.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -11.68. This value is below the healthy minimum of 3. It has decreased from 6.09 (Mar 24) to -11.68, marking a decrease of 17.77.
• For Enterprise Value (Cr.), as of Mar 25, the value is 20.78. It has increased from 13.37 (Mar 24) to 20.78, marking an increase of 7.41.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has increased from 3.23 (Mar 24) to 3.51, marking an increase of 0.28.
• For EV / EBITDA (X), as of Mar 25, the value is -30.13. This value is below the healthy minimum of 5. It has decreased from 33.62 (Mar 24) to -30.13, marking a decrease of 63.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.39. This value exceeds the healthy maximum of 3. It has increased from 3.16 (Mar 24) to 3.39, marking an increase of 0.23.
• For Price / BV (X), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 1. It has increased from -10.09 (Mar 24) to -9.67, marking an increase of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.39. This value exceeds the healthy maximum of 3. It has increased from 3.16 (Mar 24) to 3.39, marking an increase of 0.23.
• For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to -0.03, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis